Launch of the G7 Global Health Task Force
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.
JCIE Publication | A COVID-19 Emergency Response Strategy—Establishing Domestic Vaccine Development Capacity During a Public Health Emergency
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19 emergency response.
Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security
On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joined the Special Session of the Executive Committee to explain how this unprecedented global health partnership is helping develop and equitably distribute critical COVID-19 tools.
JCIE Publication | Report from Special Commission on Development Assistance for Health Calls for New ODA Approach
A report from a high-level commission organized by JCIE calls for the Japanese government to better coordinate and strategize its health ODA by creating a centralized “control tower” and to double funding for global health.
Survey of Japanese Legislators: Attitudes on ODA and Global Health
A JCIE survey of Japanese legislators finds that 80 percent of the 92 respondents favor steps to increase Japan’s official development assistance (ODA), with most prioritizing funding for health programs and education, followed by water & sanitation projects and humanitarian assistance.
JCIE Publication | A UHC Approach to Harmonizing Asian Pharmaceutical and Medical Device Regulations
The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia examines specific areas Japan should tackle in order to promote regulatory harmonization and establish infrastructure for clinical development in Asia.
Reformulating Japan’s Global Health ODA to Meet Changing Global Needs
More than 30 senior government officials, health experts, and leaders from international organizations gathered to discuss the direction Japan should take to improve its developmental assistance for health (DAH) strategy and to adapt to the changing international context.
JCIE Publication | Formulating a Grand Design for Asian Pharmaceutical & Medical Device Regulatory Harmonization
The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia highlight a need for regulatory harmonization and cross-sectoral cooperation.
Development Assistance for Health Special Commission
With just 10 more years until the Sustainable Development Goals’ (SDG) target year of 2030, there is a pressing need for Japan to increase the development impact of its global health assistance and make global health funding more strategic. This commission aims to reassess how to utilize Japan’s ODA in a more strategic manner to advance global health, adapt to structural shifts in the development field, and increase the efficacy and impact of its funding.
JCIE Report | Advancing a Global Health Agenda in the SDG Era: Enhancing Japan’s Leadership Role in 2019–2020
This report details the insights from an ad hoc, 15-member “JCIE International Advisory Group on Global Health (IAG)” on the topic of supporting countries in implementing universal health coverage and advancing health and welfare of societies.